Hexosomes formed from glycerate surfactants--formulation as a colloidal carrier for irinotecan

International Journal of Pharmaceutics
Ben J BoydGreg Davey

Abstract

A new class of amphiphiles with a glycerate headgroup, recently shown to form reverse hexagonal phase in excess water, have been dispersed to form Hexosome dispersions comprising sub-200 nm particles retaining the internal nanostructure of the parent H(II) phase. The application of these novel materials to the development of a new injectable formulation of irinotecan was investigated. The formulation of irinotecan with a small percentage of oleic acid in oleyl glycerate permitted a clinically relevant dose of irinotecan to be dissolved in the glycerate surfactant and dispersed in aqueous medium to form an injectable particle-based dose form of irinotecan. Importantly, incorporation of irinotecan into Hexosomes at neutral pH did not result in conversion from the active lactone to the inactive carboxylate form on storage, and is hence a promising alternative to the current low pH formulation of irinotecan required to inhibit this conversion. Although release of irinotecan from the Hexosomes was shown to be virtually instantaneous from the Hexosomes on substantial dilution, the retention of the drug in lactone form at neutral pH demonstrates a potential application of these novel nanostructured particles in injectable drug delivery.

References

Oct 1, 1996·Clinical and Experimental Pharmacology & Physiology·L P Rivory
Jan 20, 2000·Chemistry and Physics of Lipids·H Qiu, M Caffrey
Apr 20, 2001·Advanced Drug Delivery Reviews·J C ShahD M Chilukuri
Jul 5, 2003·International Journal of Pharmaceutics·Ben J Boyd
Jul 21, 2004·Colloids and Surfaces. B, Biointerfaces·Thomas AbrahamMitsuhiro Hirai

❮ Previous
Next ❯

Citations

Jul 25, 2012·Therapeutic Delivery·Thanigaivel Shanmugam, Rinti Banerjee
Oct 15, 2013·New Biotechnology·Rita CortesiElisabetta Esposito
Nov 19, 2011·Drug Development and Industrial Pharmacy·Ling-Ling ZhangAi-Qin Wang
Feb 5, 2014·Expert Opinion on Drug Delivery·Alexandre LancelotJosé Luis Serrano
Aug 19, 2010·Expert Opinion on Drug Delivery·Vincent Faivre, Véronique Rosilio
Sep 23, 2010·Expert Opinion on Drug Delivery·Shakila B RizwanSarah Hook
Feb 24, 2016·International Journal of Pharmaceutics·Nada MatouguiPatrick Saulnier
Feb 22, 2011·Journal of Pharmaceutical Sciences·Fábia Cristina RossettiMaria Vitória Lopes Badra Bentley
Dec 15, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Fábia Cristina RossettiMaria Vitória Lopes Badra Bentley
Apr 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tri-Hung NguyenBen J Boyd
Feb 12, 2011·International Journal of Pharmaceutics·Judith KuntscheHeike Bunjes
Feb 2, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yiqing TangAndrew L Lewis
Mar 1, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wye-Khay FongCornelia B Landersdorfer
Nov 19, 2015·Acta Pharmaceutica Sinica. B·Mohamed NasrAhmed Abdelazem
Nov 4, 2009·Pharmaceutical Development and Technology·Deshika ReddyLisa C du Toit
Jul 6, 2014·BioMed Research International·Yulin ChenShuangying Gui
Dec 30, 2014·Colloids and Surfaces. B, Biointerfaces·Amelia M Avachat, Shreekrishna S Parpani
Aug 10, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vaskor BalaClive A Prestidge
Mar 30, 2016·Langmuir : the ACS Journal of Surfaces and Colloids·Nhiem TranXavier Mulet
Oct 12, 2010·Drug Discovery Today·Chenyu GuoGuangxi Zhai
May 12, 2017·Langmuir : the ACS Journal of Surfaces and Colloids·Jean-Luc PutauxDenis Wouessidjewe
Aug 18, 2009·Colloids and Surfaces. B, Biointerfaces·Dima LibsterNissim Garti
Feb 6, 2007·Journal of Colloid and Interface Science·Dima LibsterNissim Garti
May 8, 2015·Physical Chemistry Chemical Physics : PCCP·Celesta FongCalum J Drummond
Mar 4, 2021·Journal of Nanoscience and Nanotechnology·Sergio MurgiaClaudia Caltagirone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.